Eastman EMN · NYSE
$64.91 -0.61% (-$0.40)
Summary
59 / 100 · Bulios Score
What speaks for it
- It has raised its dividend 13 years in a row.
- It has been profitable 6 years in a row.
What to watch
- Revenue fell by 6.0% a year over the last 3 years.
- 87% of profit goes to the dividend, leaving little room to raise it.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.2 USD for 1 USD of yearly profit. Over the last five years it was 14.3 USD on average.
Valuation in detailIs it growing?
It is shrinkingRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 0.7% a year over 5 years. Over the last 3 years it fell by 6.0% a year. For the next fiscal year analysts expect revenue to grow by 5.9%. Earnings per share fell by 14% a year over the last 3 years.
Growth in detailDoes it make money?
ReasonablyWhere 100 USD of revenue goes
- Cost of sales 80 USD
- Research and development 2.8 USD
- Sales and administration 7.7 USD
- Taxes and other 4.4 USD
- Net profit 5.0 USD
Net profit, industry median (Chemicals - Specialty) 5.9 USD
Out of every 100 USD of revenue, 5.0 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenRepaying all its debt would take 9.7 years of free cash flow. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, stretched- Yield
- 5.38%
- Paid out of profit
- 87%
- Raised in a row
- 13 years
You receive $3.36 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 19
- Hold 15
- Sell 1
Today's price within the analysts' price targets
The average target of $78.22 is 21% above today's price. 54% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Additives And Functional Products 33%
- Advanced Materials 33%
- Chemical Intermediates 22%
- Fibers 12%
By region
- All Foreign Countries 47%
- UNITED STATES 42%
- Asia Pacific 11%
Additives And Functional Products brings in 33% of revenue. Fibers grew fastest, by 3.9% a year.
Segments in detail